Semin Respir Crit Care Med 1999; 20(6): 591-599
DOI: 10.1055/s-2007-1009478
Copyright © 1999 by Thieme Medical Publishers, Inc.

The Immunology and Prevention of Isocyanate Asthma: A Model for Low Molecular Weight Asthma

Carrie A. Redlich, Hilary Cain, Adam V. Wisnewski
  • Yale Occupational and Environmental Medicine Program and Pulmonary and Critical Care Section, Yale University School of Medicine, New Haven, Connecticut
Further Information

Publication History

Publication Date:
20 March 2008 (online)

Abstract

Isocyanate asthma, the most common identified cause of occupational asthma in industrialized countries, is an immunologic lung disorder involving in part non-IgE-mediated pathways. Recognition and diagnosis can be difficult, and isocyanate asthma often persists, even after removal from exposure. The pathogenesis of isocyanate asthma remains poorly defined, in part because of the marked biological reactivity of isocyanates and uncertainty regarding the biologically relevant antigens. Growing evidence supports an important role for T lymphocytes and airway inflammation in mediating isocyanate sensitization and asthma. A better understanding of the immunologic mechanisms involved in isocyanate sensitization and asthma should lead to improved diagnostic and preventive strategies.